The neutral serine proteinase, elastase, is released in large amounts by neutrophils at sites of inflammation, where it can act on a broad range of substrates, including elastin, proteoglycans and structural collagen [I] . Thus elastase has been implicated in proteolytic tissue damage within the rheumatoid joint [2, 3] . a,-Antitrypsin (AAT), also known as a,-proteinase inhibitor, is the major inhibitor of elastase. However, in samples of knee-joint synovial fluid taken from patients with rheumatoid arthritis (RA), much of the AAT is inactive as an inhibitor [4, 51. Wong & Travis (61 found that AAT isolated from a sample of stored RA synovial fluid was oxidized at a critical active-site methionine residue, suggesting that synovial fluid AAT is inactivated by reactive oxygen species in a manner analogous to that which occurs in the bronchoalveolar lavage fluid of patients with pulmonary emphysema AAT (54 kDa) inhibits elastase by forming a stable 1 : 1 AAT-elastase complex (83 kDa). The complex slowly dissociates, leaving inactive 50 kDa and 4 kDa fragments of AAT. A newly described neutrophil metalloproteinase [8, 91 also cleaves AAT to give 50 kDa and 4 kDa fragments which have lost inhibitory capacity, although the presence of this metalloproteinase in RA synovial fluid has not been demonstrated. We have therefore screened synovial fluid samples for the presence of proteolytic fragments of AAT, with a view to assessing whether, in addition to oxidation, proteolysis might play a role in the functional deficiency of AAT in RA synovial fluid.
Synovial fluid was aspirated from 17 patients with RA and 10 patients with osteoarthritis (OA). Serum was obtained from 1 1 normal control subjects. Most samples were analysed within 24 h of collection. A few samples were stored for a maximum period of 3 days at either 4°C or -60°C. Over this time period there were no significant changes in the results obtained. The molecular form of AAT in samples was determined by SDS/PAGE followed by Western blotting and immunostaining. The details are described in the legend to Fig. 1 . The blots were analysed using a digital imaging system (Seescan) to quantify the intensities of bands corresponding to the various molecular forms of AAT.
Several molecular forms of AAT were visible on Western blots of human synovial fluid (Fig. 1) . Both native (54 kDa) and proteolytically cleaved (SO kDa) forms of AAT were present in all the samples. A 4 kDa band was not detected, presumably due to a lack of immunochemical reactivity. A weak band corresponding to the AAT-elastase complex We have shown that RA synovial fluid contains, on average, about twice as much cleaved AAT as O A synovial fluid or normal serum. The proteinase( s) responsible for producing the SO kDa fragment of AAT is unknown. The 5 0 kDa band might be generated by slow dissociation from the AAT-elastase complex, but this seems unlikely in view of the apparently low level of complex in the synovial fluids. It is possible that one or more of the three latent metalloproteinases known to be present in synovial fluid 
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Western blots were scanned using a digital imaging system and the intensity of the 50 kDa band was expressed as a fraction o f the 54 kDa band intensity. The horizontal bar (-) indicates the mean value within each group. Data were parametrically distributed and statistical significance was tested by Student's t-test (see the text).
been identified. Loss of the 4 kDa fragment was associated with inactivation [8, 9] . In conclusion, our results indicate that, in addition to oxidation, proteolysis by a hitherto unidentified synovial fluid metalloproteinase might play a role in the inactivation of AAT in RA synovial fluid.
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A dermal equivalent is fabricated by the incorporation of fibroblasts into a hydrated collagen gel [ 11. The collagen lattice is contracted and reorganized by the fibroblasts in a process similar to that occurring during wound contraction. Recent reports have suggested that some growth factors found at the wound site have a role in extracellular matrix reorganization ('remodelling') during wound repair [ 21 and that the dermal equivalent system may be used to study fibroblast-extracellular matrix-growth factor interactions. The aim of the present study was to measure the effects of growth factors on collagen biosynthesis and collagenase activity by dermal fibroblasts cultured in dermal equivalents.
Human dermal fibroblast monolayer cultures were established from foreskins obtained at circumcision. They were grown and maintained in Dulbecco's modified Eagle's medium and used at passages 4-12. Hydrated collagen gels seeded with fibroblasts were prepared from rat-tail collagen [3]. Such dermal equivalents may remain attached to the culture well or may be detached after polymerization and Abbreviations used: TGF-/?, transforming growth factor /?; PDGF, platelet-derived growth factor. allowed to float. Collagen production over 4 days was measured in attached dermal equivalents seeded with 5 x 10' cells, in Costar 24-well culture plates by the incorporation of [3H]proline into collagenase-sensitive, trichloroacetic acidprecipitable protein 141. Collagenase action over 15 days was measured in detached collagen gels containing [jHH]acetic anhydride-labelled collagen and 1 x lo4 fibroblasts by measuring the release of soluble, radioactive peptides. The effects of transforming growth factor / 3 (TGF-p) and plateletderived growth factor (PDGF) were studied and serum was either eliminated from the culture medium or reduced to 2% 24 h before the assay to minimize any effects of growth factors and mitogens present in serum.
The addition of TGF-p over the range 0.5-10 ng/ml stimulated collagen production in the culture medium between 3.8-and 6.1-fold (compared with controls) with the maximum increase being observed at 4 ng of TGF-j3/ml but falling off at higher concentrations. A similar distribution was observed in the gel matrix (2.7-3.2-fold increase). The stimulatory effect of TGF-p on collagen production was shown not to be due to cell proliferation. The addition of TGF-B (0.1-10 ng/ml) inhibited collagenase activity after 24 h, but inhibition was overcome by day 10 (Fig. la) . In contrast, PDGF stimulated collagenase activity by up t o 5.8-fold by day 15 (Fig. 16) . The levels of total active and latent (i.e. trypsin-treated) collagenase were determined. In the presence of TGF-p, a decrease in the levels of the active form Vol. 18 
